Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Multicenter Analysis by the Polish Adult Leukemia Group-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Multicenter Analysis by the Polish Adult Leukemia Group

Published:2020-10 Issue:10 Volume:26 Page:1833-1839
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Markiewicz Miroslaw,Drozd-Sokolowska Joanna,Biecek Przemyslaw,Dzierzak-Mietla Monika,Boguradzki Piotr,Staniak Mateusz,Piatkowska-Jakubas Beata,Piekarska Agnieszka,Tormanowska Magdalena,Halaburda Kazimierz,Ussowicz Marek,Waszczuk-Gajda Anna,Basak Grzegorz,Bołkun Lukasz,Rybka Justyna,Sadus-Wojciechowska Maria,Giebel Sebastian,Szmigielska-Kaplon Anna,Mendek-Czajkowska Ewa,Warzybok Katarzyna,Burdacki Adrian,Dwilewicz-Trojaczek Jadwiga

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Natural history of paroxysmal nocturnal hemoglobinuria;Hillmen;N Engl J Med,1995

2. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology;Socié;Lancet,1996

3. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria;Hillmen;N Engl J Med,2006

4. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria;Brodsky;Blood,2008

5. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study;Lee;Blood,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for optimising the diagnosis and treatment of paroxysmal nocturnal haemoglobinuria in Singapore;Annals of the Academy of Medicine, Singapore;2024-06-28

2. Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab;European Journal of Clinical Pharmacology;2024-05-30

3. Safety Profile of Monoclonal Antibodies and Subsequent Drug Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria;Medicina;2024-02-24

4. Hematological response in patients with paroxysmal nocturnal hemoglobinuria treated with C5-inhibitor;Oncohematology;2024-01-27

5. Candida krusei pneumonia in graft-versus-host disease after allogeneic hematopoietic stem cell transplant for paroxysmal nocturnal hemoglobinuria: a case report;Annals of Medicine & Surgery;2023-10-12